Cargando…

1528. Rates of Peripheral Blood Culture Contamination in an Urban Children’s Hospital

BACKGROUND: Positive peripheral blood culture results are essential in guiding antimicrobial therapy in patients with bacteremia. However, false-positive results may frequently pose diagnostic issues in interpreting the test. These results can lead to increased costs and patient harm through the adm...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tam, Derek, Hengel, Kyle, Arun, Aparna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6808841/ http://dx.doi.org/10.1093/ofid/ofz360.1392

Ejemplares similares

1528. A Real-World Perspective on Treatment of CRE UTIs With Oral Agents
por: Babiker, Ahmed, et al.
Publicado: (2018)

1671. Impact of COVID-19 Pandemic on Rates of Positive Blood Cultures and Contaminations in Children
por: Aiba, Hiroyuki, et al.
Publicado: (2023)

Costs of Blood Culture Contamination: Justification for Rapid Diagnostics in a Community Hospital
por: Kassamali, Zahra, et al.
Publicado: (2017)

236. Effects Of a Blood Culture Diversion Device on Blood Culture Contamination Rates and Clinical Outcomes - A Multi-Center Study
por: Febres-Aldana, Anthony J, et al.
Publicado: (2023)

1528 Ralteragir Containing regimen, for Post Exposure Prophylaxis (PEP), well tolerated in Health Care Workers (HCW)
por: Bourgi, Kassem, et al.
Publicado: (2014)

2015. Minimal Impact of Blood Culture Contaminants on Patient Care Decisions May Limit Cost-Effectiveness of Interventions to Reduce Contamination Rates
por: Augusto. Terrero Salcedo, David, et al.
Publicado: (2019)

1528. Prevalence of Human Papillomavirus Infection and Cervical Intra-Epithelial Lesions in A Subset of Arab American Women in Southeast Michigan
por: Shallal, Anita, et al.
Publicado: (2020)

LB1528C. Ivermectin for Treatment of Mild-to-Moderate COVID-19 in the Outpatient Setting A Decentralized, Placebo-controlled, Randomized, Platform Clinical Trial
por: Naggie, Susanna
Publicado: (2022)

1528. Retrospective cohort study of factors associated with non-initiation of antiretroviral therapy among adults newly diagnosed with HIV in Andijan, Uzbekistan, 2018-2021
por: Usmanov, Shokhruh, et al.
Publicado: (2023)

157. Reducing Blood Culture Contamination Rates Through the Use of a Red Top Tube Discard
por: Ramlal, Bharat, et al.
Publicado: (2018)

Spanish explorers in the Southern United States, 1528- 1543 : the Narrative of Alvar Nuñez Cabeza de Vaca /
Publicado: (1925)

171. Gram-Positive Blood Culture Contamination Rates: A Comparative Assessment Between Verigene® and Conventional Method
por: Almaghlouth, Nouf K, et al.
Publicado: (2023)

660. Effect of the COVID-19 Pandemic on Blood Culture Contamination Rates and Quality Improvement Processes
por: Hosse, Alexander G
Publicado: (2021)

LB1528. Results from ACTIV-6: A Decentralized, Double-Blinded, Randomized, Placebo-Controlled Platform Trial of Repurposed Drugs for the Treatment of Mild-to-Moderate COVID-19
por: McCarthy, Matthew W
Publicado: (2022)

Reducing Blood Culture Contamination Rates: Experiences of Four Hospital Systems
por: Halstead, Diane C., et al.
Publicado: (2020)

2172. True Positivity of Common Blood Culture Contaminants among Pediatric Hospitalizations in the United States, 2009–2016
por: Spaulding, Alicen B, et al.
Publicado: (2019)

2014. Assessment of Cost, Morbidity, and Mortality Associated with Blood Culture Contamination
por: Davis, Kevin A, et al.
Publicado: (2019)

193. Rapid Diagnostic Testing and Vancomycin Utilization for Contaminated Blood Cultures
por: Lockridge, Connor, et al.
Publicado: (2022)

La Catedral de San Cristóbal de Las Casas, Chiapas, 1528-1978 /
por: Flores Ruiz, Eduardo, 1890-1977
Publicado: (1978)

167 Reduction in Contaminated Blood Culture Rates and Associated Costs as an Antimicrobial Stewardship Program Activity
por: Toney, John, et al.
Publicado: (2014)

502. The Impact of Combating COVID-19 on Blood Culture Contamination and Central Line Associated Bloodstream Infection Rates
por: LeRose, Jennifer, et al.
Publicado: (2020)

1148. Reduction of Blood Culture Contamination Rates by an Altered Sampling Protocol: Single-Center, Prospective, Randomized, Controlled, Open-Label Trial
por: Strahilevitz, Jacob, et al.
Publicado: (2018)

2013. Blood Culture Contamination in the Emergency Department: A Risk Factor Analysis
por: Klucher, Justin, et al.
Publicado: (2019)

Significant Reduction of Blood Culture Contamination in the Emergency Department (ED) Using the Steripath® Blood Diversion Device
por: Tongma, Chawat, et al.
Publicado: (2017)

172. Impact of a quality improvement re-training program on the blood culture volume, yield and contamination rates; experience from South India
por: Rabbani Amaanulla, Kaamil Zubair, et al.
Publicado: (2023)

PO-1528 Mood disorder in cancer patients undergoing radiotherapy during the COVID-19 outbreak
por: Nardone, V., et al.
Publicado: (2021)

Quality assurance in blood culture: A retrospective study of blood culture contamination rate in a tertiary hospital in Nigeria
por: Chukwuemeka, Iregbu Kenneth, et al.
Publicado: (2014)

118. Eliminating Blood Culture Contamination with an Initial-specimen Diversion Device
por: Tompkins, Lucy S, et al.
Publicado: (2020)

La historia de Texas en la Biblioteca Nacional de México, 1528-1848 : bibliografía comentada /
por: Curiel, Guadalupe
Publicado: (1994)

Effects of Oxygen Transference on Protease Production by Rhodotorula mucilaginosa CBMAI 1528 in a Stirred Tank Bioreactor
por: Machado, Suellen, et al.
Publicado: (2022)

Clinical education in reducing contamination rate in blood culture collection
por: Thong, ML, et al.
Publicado: (2011)

A change of culture: reducing blood culture contamination rates in an Emergency Department
por: Bentley, James, et al.
Publicado: (2016)

114. Prospective Trial of Passive Diversion Device to Reduce Blood Culture Contamination
por: Arnaout, Sami, et al.
Publicado: (2021)

P1528: GENETIC AND PHENOTYPIC CHARACTERIZATION OF HEREDITARY SPHEROCYTOSIS AND RELATED DISORDERS – DESCRIPTION OF 9 NEW GENETIC VARIANTS
por: Haeuser, F., et al.
Publicado: (2022)

188. Opportunities for antimicrobial stewardship: Time to optimal therapy and vancomycin use in gram-positive and contaminated blood cultures before and after implementation of rapid blood culture diagnostic testing
por: Olion, Kelsey, et al.
Publicado: (2022)

161. Evaluating the Predictive Value of Blood Culture Bottle Reporting for Coagulase Negative Staphylococci-Positive Cultures: Assessing Contamination vs. True Bacteremia
por: Bailey, Pamela, et al.
Publicado: (2019)

Optimization of protease production and sequence analysis of the purified enzyme from the cold adapted yeast Rhodotorula mucilaginosa CBMAI 1528
por: Lario, Luciana Daniela, et al.
Publicado: (2020)

1803. Clinical Impact of Rapid Blood Culture Diagnostics Differs by Time of Day and Gram Stain Type: Lessons From Implementation of Verigene® Blood Culture Testing in a Children’s Hospital
por: Katz, Sophie, et al.
Publicado: (2018)

908. Evaluation of Blood Culture Submission Rates in Japan
por: Tajima, Taichi, et al.
Publicado: (2020)

382. A Multifaceted Intervention to Reduce Blood Culture Contamination in Medical and Surgical Wards: A Cluster Randomized Controlled Trial
por: Sayabovorn, Naruemit, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_6q8ub4adeh23do932b76qub3l6